Weight-reducing diabetes medications may increase fall risk in patients with type 2 diabetes

Patients with low skeletal muscle mass are at a higher risk of falling. Certain diabetes medications, particularly SGLT2 inhibitors and GLP-1 receptor agonists, are associated with weight reduction, which may contribute to muscle mass loss and, consequently, an increased risk of falls. To explore this association, researchers investigated the impact of diabetes medications on fall risk in patients with type 2 diabetes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup